Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid for pain in bone metastases
NCT00434317Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2005
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of zoledronic acid in bone metastasis, sponsored by Novartis. Primary endpoint: Pain assessed by a Visual Analogue Scale. Started Aug 2005; status: completed.
02
Drugs
zoledronic acid
03
Conditions
bone metastasis
Beyond the preview
Go deeper on NCT00434317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00434317.